EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterisation of the Plasma and Faecal Metabolomes in Participants with Functional Gastrointestinal Disorders

Karl Fraser iD, Shanalee C James, Wayne Young, Richard B Gearry, Phoebe E Heenan iD, Jacqueline I Keenan, Nicholas J Talley iD, Warren C McNabb iD, Nicole C Roy iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252413465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Karl Fraser und 8 weiteren Autor:innen. Beteiligte Einrichtung: AgResearch, Tennent Drive, Palmerston North 4442, New Zealand. Hauptthemen laut MEDLINE: Feces, Metabolome, Gastrointestinal Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Zealand Ministry for Business, Innovation and Employment, Ministry for Business, Innovation and Employment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is evidence of perturbed microbial and host processes in the gastrointestinal tract of individuals with functional gastrointestinal disorders (FGID) compared to healthy controls. The faecal metabolome provides insight into the metabolic processes localised to the intestinal tract, while the plasma metabolome highlights the overall perturbances of host and/or microbial responses. This study profiled the faecal (n = 221) and plasma (n = 206) metabolomes of individuals with functional constipation (FC), constipation-predominant irritable bowel syndrome (IBS-C), functional diarrhoea (FD), diarrhoea-predominant IBS (IBS-D) and healthy controls (identified using the Rome Criteria IV) using multimodal LC-MS technologies. Discriminant analysis separated patients with the ‘all constipation’ group (FC and IBS-C) from the healthy control group and ‘all diarrhoea’ group (FD and IBS-D) from the healthy control group in both sample types. In plasma, almost all multimodal metabolite analyses separated the ‘all constipation’ or ‘all diarrhoea’ group from the healthy controls, and the IBS-C or IBS-D group from the healthy control group. Plasma phospholipids and metabolites linked to several amino acid and nucleoside pathways differed (p < 0.05) between healthy controls and IBS-C. In contrast, metabolites involved in bile acid and amino acid metabolism were the key differentiating classes in the plasma of subjects with IBS-D from healthy controls. Faecal lipids, particularly ceramides, diglycerides, and triglycerides, varied (p < 0.05) between healthy controls and the ‘all constipation’ group and between healthy controls and ‘all diarrhoea’ group. The faecal and plasma metabolomes showed perturbations between constipation, diarrhoea and healthy control groups that may reflect processes and mechanisms linked to FGIDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesMetabolomeGastrointestinal DiseasesHumansMaleFemaleAdultMiddle AgedConstipationIrritable Bowel SyndromeDiarrheaMetabolomicsCase-Control Studies

Stichwörter der Autor:innen

LC-MSbiomarkersconstipationdiarrhoeagut-brainmetabolomics

Autor:innen und Institutionen

  • AgResearch, Tennent Drive, Palmerston North 4442, New Zealand.
  • The Riddet Institute, Massey University, Palmerston North 4474, New Zealand.
  • High-Value Nutrition National Science Challenge, Auckland 1023, New Zealand.
  • School of Food and Advanced Technology, Massey University, Palmerston North 4472, New Zealand.
  • Department of Medicine, University of Otago, Christchurch 8011, New Zealand.
  • Department of Surgery, University of Otago, Christchurch 8011, New Zealand.

ORCID-Profile: Karl Fraser, Phoebe E Heenan, Nicholas J Talley, Warren C McNabb, Nicole C Roy

Förderung

  • New Zealand Ministry for Business, Innovation and Employment
  • Ministry for Business, Innovation and Employment

Zitieren

APA

Fraser, K., James, S. C., Young, W., Gearry, R. B., Heenan, P. E., Keenan, J. I., Talley, N. J., McNabb, W. C., & Roy, N. C. (2024). Characterisation of the Plasma and Faecal Metabolomes in Participants with Functional Gastrointestinal Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413465

Vancouver

Fraser K, James SC, Young W, Gearry RB, Heenan PE, Keenan JI, et al. Characterisation of the Plasma and Faecal Metabolomes in Participants with Functional Gastrointestinal Disorders. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413465

BibTeX
@article{Fraser2024,
  author = {Fraser, Karl and James, Shanalee C and Young, Wayne and Gearry, Richard B and Heenan, Phoebe E and Keenan, Jacqueline I and Talley, Nicholas J and McNabb, Warren C and Roy, Nicole C},
  title = {Characterisation of the Plasma and Faecal Metabolomes in Participants with Functional Gastrointestinal Disorders},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252413465}
}
Kostenlos starten →